Comerica Bank Halozyme Therapeutics, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Comerica Bank holds 109,102 shares of HALO stock, worth $5.35 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

109,102

Previous 78,722 38.59%

Holding current value

$5.35 Million

Previous $4.12 Million 51.44%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $1.56 Million - $1.96 Million	30,380 Added 38.59%	109,102 $6.24 Million
Q2 2024 Aug 15, 2024	SELL	$37.81 - $52.4 $162,053 - $224,586	-4,286 Reduced 5.16%	78,722 $4.12 Million
Q1 2024 May 15, 2024	SELL	$33.68 - $41.95 $76,824 - $95,687	-2,281 Reduced 2.67%	83,008 $3.38 Million
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $48,347 - $61,087	-1,451 Reduced 1.67%	85,289 $3.15 Million
Q3 2023 Nov 21, 2023	BUY	$36.46 - $44.03 $3.16 Million - $3.82 Million	86,740 New	86,740 $3.31 Million
Q4 2022 Jan 26, 2023	SELL	$40.06 - $59.44 $78,838 - $116,977	-1,968 Reduced 3.05%	62,557 $0
Q3 2022 Oct 28, 2022	BUY	$38.53 - $51.78 $51,360 - $69,022	1,333 Added 2.11%	64,525 $3.01 Million
Q2 2022 Aug 02, 2022	SELL	$37.35 - $48.3 $60,133 - $77,763	-1,610 Reduced 2.48%	63,192 $3.16 Million
Q1 2022 Apr 27, 2022	SELL	$31.97 - $41.06 $713,602 - $916,500	-22,321 Reduced 25.62%	64,802 $2.58 Million
Q4 2021 Feb 18, 2022	SELL	$31.82 - $40.75 $63,958 - $81,907	-2,010 Reduced 2.26%	87,123 $3.5 Million
Q3 2021 Nov 22, 2021	SELL	$38.47 - $46.42 $426,593 - $514,751	-11,089 Reduced 11.06%	89,133 $3.63 Million
Q2 2021 Aug 26, 2021	SELL	$38.84 - $51.31 $76,980 - $101,696	-1,982 Reduced 1.94%	100,222 $4.55 Million
Q1 2021 Apr 28, 2021	SELL	$39.51 - $51.45 $102,488 - $133,461	-2,594 Reduced 2.48%	102,204 $4.26 Million
Q4 2020 Jan 28, 2021	BUY	$25.81 - $43.62 $1.76 Million - $2.98 Million	68,375 Added 187.72%	104,798 $4.48 Million
Q3 2020 Oct 30, 2020	SELL	$25.74 - $29.63 $118,687 - $136,623	-4,611 Reduced 11.24%	36,423 $957,000
Q2 2020 Jul 31, 2020	BUY	$16.25 - $26.81 $6,808 - $11,233	419 Added 1.03%	41,034 $1.1 Million
Q1 2020 May 01, 2020	BUY	$13.9 - $21.83 $564,548 - $886,625	40,615 New	40,615 $730,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.83B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account